Literature DB >> 3827521

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

T R Kosten, B J Rounsaville, H D Kleber.   

Abstract

During a 2.5-year follow-up study of opioid addicts, we found that cocaine abuse had become an increasing and major problem through 1983. Cocaine abuse had only minimally declined during the follow-up period despite treatment, and the number of opioid addicts with at least weekly cocaine abuse had doubled. The clear effect of methadone maintenance treatment in reducing opioid abuse was not evident for cocaine abuse. During the follow-up period, more cocaine use was reported by the methadone-treated subjects than by those undergoing detoxification only. Prognostically, cocaine users were more likely to be nonwhites and men. Subjects who increased their cocaine use during the follow-up period were more likely to have depressive disorders and more likely to be found among methadone- and "drug-free"-treated subjects than among detoxification subjects. Thus, among methadone- and drug-free-treated subjects, depression appeared to be a risk factor for escalating cocaine abuse; this risk factor may benefit from specific interventions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827521     DOI: 10.1001/archpsyc.1987.01800150101012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  21 in total

1.  Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment.

Authors:  Donald A Calsyn; Frank J DeMarco; Andrew J Saxon; Kevin L Sloan; Karen E Gibbon
Journal:  Am J Public Health       Date:  2003-07       Impact factor: 9.308

2.  Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.

Authors:  Mireia Jofre-Bonet; Jody L Sindelar; Ismene L Petrakis; Charla Nich; Tami Frankforter; Bruce J Rounsaville; Kathleen M Carroll
Journal:  J Subst Abuse Treat       Date:  2004-04

3.  Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats.

Authors:  Sara J Ward; Christopher Läck; Drake Morgan; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2006-01-14       Impact factor: 4.530

4.  Enhancement of cocaine's abuse liability in methadone maintenance patients.

Authors:  K L Preston; J T Sullivan; E C Strain; G E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self-administration.

Authors:  Lindsey P Pattison; Scot McIntosh; Evgeny A Budygin; Scott E Hemby
Journal:  J Neurochem       Date:  2012-05-23       Impact factor: 5.372

6.  Self-administered heroin and cocaine combinations in the rat: additive reinforcing effects-supra-additive effects on nucleus accumbens extracellular dopamine.

Authors:  James E Smith; Conchita Co; Michael D Coller; Scott E Hemby; Thomas J Martin
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

7.  Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.

Authors:  Frances R Levin; Adam Bisaga; Wilfrid Raby; Efrat Aharonovich; Eric Rubin; John Mariani; Daniel J Brooks; Fatima Garawi; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2007-06-15

8.  Self-administration of cocaine-pentobarbital mixtures by rhesus monkeys.

Authors:  W L Woolverton; Zhixia Wang
Journal:  Drug Alcohol Depend       Date:  2008-12-03       Impact factor: 4.492

9.  Meta-analysis of depression and substance use and impairment among cocaine users.

Authors:  Kenneth R Conner; Martin Pinquart; Amanda P Holbrook
Journal:  Drug Alcohol Depend       Date:  2008-06-27       Impact factor: 4.492

10.  Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of action.

Authors:  W L Woolverton; Zhixia Wang; Theresa Vasterling; F Ivy Carroll; Ronald Tallarida
Journal:  Psychopharmacology (Berl)       Date:  2007-11-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.